about
Collagen XXIII, novel ligand for integrin alpha2beta1 in the epidermisEpithelial Anion Transport as Modulator of Chemokine SignalingCollagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domainRibosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression DefectSynergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.Expression of type XXIII collagen mRNA and protein.Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.Potentiators of Defective ΔF508-CFTR Gating that Do Not Interfere with Corrector Action.From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations.Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice.Collagen XXII binds to collagen-binding integrins via the novel motifs GLQGER and GFKGER.Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.Type XIV Collagen Regulates Fibrillogenesis: PREMATURE COLLAGEN FIBRIL GROWTH AND TISSUE DYSFUNCTION IN NULL MICE.Mutation-specific downregulation of CFTR2 variants by gating potentiators.Extracellular oxidation in Cystic Fibrosis airway epithelium causes enhanced EGFR/ADAM17 activity.Structure-guided combination therapy to potently improve the function of mutant CFTRsChaperone-Independent Peripheral Quality Control of CFTR by RFFL E3 Ligase.Collagen XII interacts with avian tenascin-X through its NC3 domainΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 ReporterBioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and ActivityTranscytosis maintains CFTR apical polarity in the face of constitutive and mutation-induced basolateral missorting
P50
Q24623955-6DDF2D04-5AF1-4728-AA0B-459F9EFDDBB6Q26744381-0BC51323-7E8B-46DA-861B-80BFBFF020DCQ28510535-B6D2CF8C-0A38-4908-B92F-F86A6C4AD89CQ28551966-7568BEC8-1EC7-43C6-A1F4-08E9F654D13FQ33742766-D4CDE30A-5B67-49ED-A5B4-40AEDC95234BQ34530822-49BE5BB2-195D-482D-82F3-DFE711DA3CA4Q35743348-4A2F10BF-B5FB-47F9-87E1-E46C9615BC12Q36077743-68EC625C-32BA-466B-81D4-E1125550C915Q36574664-13CB952E-AE7C-4AC5-8E7A-AED62D168F08Q37685735-546AB10F-3B26-418A-98C3-3CA236E9446BQ39034184-8526F592-FBD5-4CA8-BFDF-E82AD43EF84FQ41565850-8EDBA179-686B-4144-96AE-1EB20683C63FQ42044119-2C0CAD17-56C8-4B00-B246-BCF166F6CBAAQ47741272-D9D84D09-7040-4945-9744-B59BEB21A191Q49917927-AE5D639A-D894-4BFF-A71D-7E5C62ABA6E2Q57295554-1C36A5EC-A896-47EB-B704-3C2FF53CC1EEQ64986365-FEACF616-60E6-414C-BB22-83A0B1E8B736Q79966217-4B5D2288-8188-49D0-892A-86441B53F90CQ88039762-347004CB-FBB1-46C8-AD8B-F4B43018D0C3Q91936980-370CFFE4-AF98-46B2-84D2-9A6D780DC31FQ93040694-1C5C6B27-0BC7-4396-B482-74144BCFCBF2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Guido Veit
@ast
Guido Veit
@en
Guido Veit
@es
Guido Veit
@nl
Guido Veit
@sl
type
label
Guido Veit
@ast
Guido Veit
@en
Guido Veit
@es
Guido Veit
@nl
Guido Veit
@sl
prefLabel
Guido Veit
@ast
Guido Veit
@en
Guido Veit
@es
Guido Veit
@nl
Guido Veit
@sl
P106
P1153
12803679200
P21
P31
P496
0000-0002-6758-2696